Filed: 10/23/2023ACC: 0001754960-23-000287
📋 What this filing means
BML CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 26 equity positions with a total reported market value of $108.90M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
26
Positions
$108.90M
Total AUM (reported)
29.58M
Total Shares
Allocation by class
COM$60.25M55.3%
0-3 MNTH TREASRY$27.18M25.0%
BLOOMBERG 1-3 MO$18.36M16.9%
COM NEW$2.67M2.4%
UNIT SER 1$443.9K0.4%
Portfolio Concentration
Top 3$59.94M55.0%
4–10$37.65M34.6%
11–25$11.26M10.3%
Rest$43.7K0.0%
Top 3 weight
55.0%
Top 10 weight
89.6%
Voting Authority Distribution
Total shares with voting rights: 29.58M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
29.58M
shares
% of voting shares100.0%
Investment Discretion (by position count)
Sole26
Shared0
Other0
Dominant voting typeNone · 100.0% of voting shares
Institutional Holdings26
Rows:
ISHARES TR
SOLEShares270K
TypeSH
Market value$27.18M
24.96%
Sole
0.00
Shared
0.00
None
270K
SPDR SER TR
SOLEShares200K
TypeSH
Market value$18.36M
16.86%
Sole
0.00
Shared
0.00
None
200K
ATEA PHARMACEUTICALS INC
SOLEShares4.80M
TypeSH
Market value$14.40M
13.22%
Sole
0.00
Shared
0.00
None
4.80M
CYTEIR THERAPEUTICS INC
SOLEShares3.25M
TypeSH
Market value$9.23M
8.48%
Sole
0.00
Shared
0.00
None
3.25M
AVROBIO INC
SOLEShares4M
TypeSH
Market value$6.16M
5.66%
Sole
0.00
Shared
0.00
None
4M
ADVERUM BIOTECHNOLOGIES INC
SOLEShares3.92M
TypeSH
Market value$5.87M
5.39%
Sole
0.00
Shared
0.00
None
3.92M
TALARIS THERAPEUTICS INC
SOLEShares2M
TypeSH
Market value$5.62M
5.16%
Sole
0.00
Shared
0.00
None
2M
ELIEM THERAPEUTICS INC
SOLEShares1.94M
TypeSH
Market value$5.10M
4.68%
Sole
0.00
Shared
0.00
None
1.94M
ATHIRA PHARMA INC
SOLEShares1.70M
TypeSH
Market value$3.44M
3.16%
Sole
0.00
Shared
0.00
None
1.70M
ASTROTECH CORP
SOLEShares220.41K
TypeSH
Market value$2.23M
2.04%
Sole
0.00
Shared
0.00
None
220.41K
ORAMED PHARMACEUTICALS INC
SOLEShares781.29K
TypeSH
Market value$2.04M
1.87%
Sole
0.00
Shared
0.00
None
781.29K
ARCA BIOPHARMA INC
SOLEShares706.93K
TypeSH
Market value$1.42M
1.30%
Sole
0.00
Shared
0.00
None
706.93K
PASSAGE BIO INC
SOLEShares2.06M
TypeSH
Market value$1.35M
1.24%
Sole
0.00
Shared
0.00
None
2.06M
FORTE BIOSCIENCES INC
SOLEShares1.76M
TypeSH
Market value$1.17M
1.07%
Sole
0.00
Shared
0.00
None
1.76M
MILESTONE PHARMACEUTICALS IN
SOLEShares272.50K
TypeSH
Market value$844.8K
0.78%
Sole
0.00
Shared
0.00
None
272.50K
ENLIVEN THERAPEUTICS INC
SOLEShares50K
TypeSH
Market value$683.0K
0.63%
Sole
0.00
Shared
0.00
None
50K
RETRACTABLE TECHNOLOGIES INC
SOLEShares499.96K
TypeSH
Market value$595.0K
0.55%
Sole
0.00
Shared
0.00
None
499.96K
VERRICA PHARMACEUTICALS INC
SOLEShares150K
TypeSH
Market value$582.8K
0.54%
Sole
0.00
Shared
0.00
None
150K
VISTAGEN THERAPEUTICS INC
SOLEShares100K
TypeSH
Market value$524.0K
0.48%
Sole
0.00
Shared
0.00
None
100K
LISATA THERAPEUTICS INC
SOLEShares243.84K
TypeSH
Market value$521.8K
0.48%
Sole
0.00
Shared
0.00
None
243.84K
INVESCO QQQ TR
SOLEShares108.00
TypeSH
Market value$443.9K
0.41%
Sole
0.00
Shared
0.00
None
108.00
NEXTCURE INC
SOLEShares306.46K
TypeSH
Market value$395.3K
0.36%
Sole
0.00
Shared
0.00
None
306.46K
NEOLEUKIN THERAPEUTICS INC
SOLEShares98.66K
TypeSH
Market value$389.7K
0.36%
Sole
0.00
Shared
0.00
None
98.66K
CALCIMEDICA INC
SOLEShares88.78K
TypeSH
Market value$236.1K
0.22%
Sole
0.00
Shared
0.00
None
88.78K
RAIN ONCOLOGY INC
SOLEShares72.93K
TypeSH
Market value$62.8K
0.06%
Sole
0.00
Shared
0.00
None
72.93K
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ISHARES TRSOLE | 0-3 MNTH TREASRY | 270K | SH | $27.18M 24.96% | 0.00 | 0.00 | 270K |
SPDR SER TRSOLE | BLOOMBERG 1-3 MO | 200K | SH | $18.36M 16.86% | 0.00 | 0.00 | 200K |
ATEA PHARMACEUTICALS INCSOLE | COM | 4.80M | SH | $14.40M 13.22% | 0.00 | 0.00 | 4.80M |
CYTEIR THERAPEUTICS INCSOLE | COM | 3.25M | SH | $9.23M 8.48% | 0.00 | 0.00 | 3.25M |
AVROBIO INCSOLE | COM | 4M | SH | $6.16M 5.66% | 0.00 | 0.00 | 4M |
ADVERUM BIOTECHNOLOGIES INCSOLE | COM | 3.92M | SH | $5.87M 5.39% | 0.00 | 0.00 | 3.92M |
TALARIS THERAPEUTICS INCSOLE | COM | 2M | SH | $5.62M 5.16% | 0.00 | 0.00 | 2M |
ELIEM THERAPEUTICS INCSOLE | COM | 1.94M | SH | $5.10M 4.68% | 0.00 | 0.00 | 1.94M |
ATHIRA PHARMA INCSOLE | COM | 1.70M | SH | $3.44M 3.16% | 0.00 | 0.00 | 1.70M |
ASTROTECH CORPSOLE | COM | 220.41K | SH | $2.23M 2.04% | 0.00 | 0.00 | 220.41K |
ORAMED PHARMACEUTICALS INCSOLE | COM NEW | 781.29K | SH | $2.04M 1.87% | 0.00 | 0.00 | 781.29K |
ARCA BIOPHARMA INCSOLE | COM | 706.93K | SH | $1.42M 1.30% | 0.00 | 0.00 | 706.93K |
PASSAGE BIO INCSOLE | COM | 2.06M | SH | $1.35M 1.24% | 0.00 | 0.00 | 2.06M |
FORTE BIOSCIENCES INCSOLE | COM | 1.76M | SH | $1.17M 1.07% | 0.00 | 0.00 | 1.76M |
MILESTONE PHARMACEUTICALS INSOLE | COM | 272.50K | SH | $844.8K 0.78% | 0.00 | 0.00 | 272.50K |
ENLIVEN THERAPEUTICS INCSOLE | COM | 50K | SH | $683.0K 0.63% | 0.00 | 0.00 | 50K |
RETRACTABLE TECHNOLOGIES INCSOLE | COM | 499.96K | SH | $595.0K 0.55% | 0.00 | 0.00 | 499.96K |
VERRICA PHARMACEUTICALS INCSOLE | COM | 150K | SH | $582.8K 0.54% | 0.00 | 0.00 | 150K |
VISTAGEN THERAPEUTICS INCSOLE | COM | 100K | SH | $524.0K 0.48% | 0.00 | 0.00 | 100K |
LISATA THERAPEUTICS INCSOLE | COM | 243.84K | SH | $521.8K 0.48% | 0.00 | 0.00 | 243.84K |
INVESCO QQQ TRSOLE | UNIT SER 1 | 108.00 | SH | $443.9K 0.41% | 0.00 | 0.00 | 108.00 |
NEXTCURE INCSOLE | COM | 306.46K | SH | $395.3K 0.36% | 0.00 | 0.00 | 306.46K |
NEOLEUKIN THERAPEUTICS INCSOLE | COM NEW | 98.66K | SH | $389.7K 0.36% | 0.00 | 0.00 | 98.66K |
CALCIMEDICA INCSOLE | COM NEW | 88.78K | SH | $236.1K 0.22% | 0.00 | 0.00 | 88.78K |
RAIN ONCOLOGY INCSOLE | COM | 72.93K | SH | $62.8K 0.06% | 0.00 | 0.00 | 72.93K |
Page 1 of 2